by Stephen Levin
While the emergence of so-called quality-of-life (QOL) medicine has had a greater impact in pharmaceuticals, the medical device industry has...
Satiety: Treating Obesity Beyond Quality of Life
Obesity is no longer merely a lifestyle-related condition; it's a worldwide epidemic with life-threatening consequences. Satiety is developing a device-based alternative to surgery that could expand the market for both physicians and patients.
More from Innovation
More from In Vivo
• By
Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy
• By
Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.
• By
In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.